MedTrace Logo

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip

NCT02065167 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-10-14

No results posted yet for this study

Summary

The purpose is to assess the safety and feasibility of cellular therapy derived from bone marrow, to help bone healing in patients with avascular necrosis of the hip.

Conditions

  • Avascular Necrosis of the Femoral Head

Interventions

BIOLOGICAL

Cultured autologous Mesenchymal Cells

Cultured Mesenchymal Cells from bone marrow isolation, expanded under GMP protocol in associated facilities and introduced at the end of the appropriate forage up to the femoral head under fluoroscopic control.

Sponsors & Collaborators

  • Universidad Autonoma de Madrid

    lead OTHER

Principal Investigators

  • Enrique Gomez-Barrena, Prof · Universidad Autonoma de Madrid, Hospital la Paz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-30
Completion
2017-12-31

Countries

  • France
  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02065167 on ClinicalTrials.gov